(833) 317-6278
Book a Demo
Max Bayer
Gray shield icon
Is this you?
Claim your profile.

Max Bayer

Pharma Reporter

AS SEEN ON
Endpoints News

Preston's Summary

Max Bayer is a Staff Writer at Biotech. He covers a range of topics including medicine and healthcare, finance, and the evolving landscape of cannabis and psychedelics, with a particular focus on biotech, business leaders, and startups. Max's work has been featured in notable publications such as Fierce Pharma and Endpoints News.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Press Release: 37 %
Private Sector Announcements: 15 %
Government Announcement: 13 %
Cites Data: 13 %
Legal Policy Regulation: 7 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Healthcare Administration
  • Oncology
  • Corporate Finance
  • Startups
  • Mental Health Care
  • Gene Therapy

Pitching Insights

Max Bayer's coverage primarily focuses on the healthcare and pharmaceutical industry, specifically on biotech, drug development, FDA approvals, and clinical trials. His articles often contain press releases and cite data from private sector announcements.

To effectively reach out to Max Bayer, consider providing pitches related to groundbreaking advancements in biotechnology or pharmaceuticals with a focus on new drug applications, significant leadership changes within prominent companies in the industry, as well as noteworthy partnerships or deals between key players. Additionally, offering insights supported by reliable data could enhance the appeal of your pitch.

Given that Max Bayer does not have a specific geographic focus mentioned but covers global developments within the healthcare and pharmaceutical sectors, ensure that your pitches reflect international relevance rather than being region-specific.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Nicole Defeudis

Nicole Defeudis

Editor
*****e@********om
Publications
Endpoints News
Most recent topics
Not enough data
Paul Schloesser

Paul Schloesser

Associate Editor
Publications
Endpoints News
Most recent topics
Not enough data
Amber Tong

Amber Tong

Senior Editor
****r@**************com
Publications
Bloomberg News, Financial Advisor Magazine, Boston Globe Technology, The Irish Times
Most recent topics
Not enough data
Max Gelman

Max Gelman

Senior Editor
**x@**************com
Publications
Endpoints News
Most recent topics
Not enough data
Reynald Castaneda

Reynald Castaneda

********da@********om
Publications
Endpoints News
Most recent topics
Not enough data
Ayisha Sharma

Ayisha Sharma

Biopharma Breaking News Reporter
******a@********om
Publications
Endpoints News
Most recent topics
Not enough data

Articles

© 2025 Intelligent Relations